Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Ovis aries | Cyclooxygenase-1 | Starlite/ChEMBL | References |
Homo sapiens | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | Starlite/ChEMBL | References |
Homo sapiens | prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0111 | 0.1143 | 1 |
Toxoplasma gondii | DNA-directed RNA polymerase I RPA2 | 0.003 | 0.0121 | 0.4474 |
Trichomonas vaginalis | DNA-directed RNA polymerase III subunit, putative | 0.0042 | 0.027 | 0.5 |
Trypanosoma cruzi | DNA-directed RNA polymerase III, putative | 0.0042 | 0.027 | 1 |
Loa Loa (eye worm) | RNA polymerase III 128kD subunit-PA | 0.0042 | 0.027 | 0.2363 |
Trypanosoma brucei | DNA-directed RNA polymerase II subunit 2, putative | 0.0042 | 0.027 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0111 | 0.1143 | 1 |
Onchocerca volvulus | Peroxidase homolog | 0.0111 | 0.1143 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0111 | 0.1143 | 1 |
Trypanosoma brucei | DNA-directed RNA polymerase III, putative | 0.0042 | 0.027 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0111 | 0.1143 | 1 |
Onchocerca volvulus | Dual oxidase homolog | 0.0111 | 0.1143 | 1 |
Giardia lamblia | DNA-directed RNA polymerase subunit B | 0.003 | 0.0121 | 0.4474 |
Loa Loa (eye worm) | hypothetical protein | 0.0111 | 0.1143 | 1 |
Schistosoma mansoni | DNA-directed RNA polymerase III subunit | 0.0042 | 0.027 | 0.2363 |
Loa Loa (eye worm) | animal heme peroxidase | 0.0111 | 0.1143 | 1 |
Echinococcus multilocularis | peroxidasin | 0.0111 | 0.1143 | 1 |
Brugia malayi | DNA-directed RNA polymerase, beta subunit family protein | 0.0042 | 0.027 | 0.2363 |
Loa Loa (eye worm) | DNA-directed RNA polymerase | 0.0034 | 0.0176 | 0.1538 |
Echinococcus granulosus | DNA directed RNA polymerase I subunit RPA2 | 0.0042 | 0.027 | 0.2363 |
Brugia malayi | DNA-directed RNA polymerase II second largest subunit, putative | 0.0042 | 0.027 | 0.2363 |
Loa Loa (eye worm) | hypothetical protein | 0.0111 | 0.1143 | 1 |
Mycobacterium ulcerans | DNA-directed RNA polymerase subunit beta | 0.0813 | 1 | 0.5 |
Onchocerca volvulus | Peroxidasin homolog | 0.0111 | 0.1143 | 1 |
Echinococcus granulosus | peroxidasin | 0.0111 | 0.1143 | 1 |
Plasmodium vivax | DNA-directed RNA polymerase III subunit, putative | 0.0042 | 0.027 | 1 |
Brugia malayi | Animal haem peroxidase family protein | 0.0111 | 0.1143 | 1 |
Brugia malayi | Animal haem peroxidase family protein | 0.0111 | 0.1143 | 1 |
Brugia malayi | Blistered cuticle protein 3 | 0.0111 | 0.1143 | 1 |
Plasmodium falciparum | DNA-directed RNA polymerase subunit beta, putative | 0.0221 | 0.2529 | 1 |
Giardia lamblia | DNA-directed RNA polymerase subunit B | 0.0042 | 0.027 | 1 |
Schistosoma mansoni | peroxidasin | 0.0111 | 0.1143 | 1 |
Echinococcus multilocularis | DNA directed RNA polymerase I subunit RPA2 | 0.0042 | 0.027 | 0.2363 |
Loa Loa (eye worm) | animal heme peroxidase | 0.0111 | 0.1143 | 1 |
Loa Loa (eye worm) | animal heme peroxidase | 0.0111 | 0.1143 | 1 |
Loa Loa (eye worm) | animal heme peroxidase | 0.0111 | 0.1143 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0111 | 0.1143 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0111 | 0.1143 | 1 |
Echinococcus multilocularis | DNA directed RNA polymerase III subunit RPC2 | 0.0042 | 0.027 | 0.2363 |
Wolbachia endosymbiont of Brugia malayi | DNA-directed RNA polymerase subunit beta/beta' | 0.0813 | 1 | 0.5 |
Treponema pallidum | DNA-directed RNA polymerase subunit beta | 0.0813 | 1 | 0.5 |
Trichomonas vaginalis | DNA-directed RNA polymerase I subunit, putative | 0.0042 | 0.027 | 0.5 |
Trichomonas vaginalis | DNA-directed RNA polymerase I subunit, putative | 0.0042 | 0.027 | 0.5 |
Schistosoma mansoni | DNA-directed RNA polymerase I subunit | 0.003 | 0.0121 | 0.1057 |
Loa Loa (eye worm) | blistered cuticle protein 3 | 0.0111 | 0.1143 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0111 | 0.1143 | 1 |
Brugia malayi | DNA-directed RNA polymerase III subunit 127.6 kDa polypeptide | 0.0042 | 0.027 | 0.2363 |
Loa Loa (eye worm) | hypothetical protein | 0.0111 | 0.1143 | 1 |
Echinococcus granulosus | DNA directed RNA polymerase III subunit RPC2 | 0.0042 | 0.027 | 0.2363 |
Schistosoma mansoni | DNA-directed rna polymerase II subunit | 0.0042 | 0.027 | 0.2363 |
Loa Loa (eye worm) | hypothetical protein | 0.0111 | 0.1143 | 1 |
Onchocerca volvulus | Chorion peroxidase homolog | 0.0111 | 0.1143 | 1 |
Toxoplasma gondii | DNA-directed RNA polymerase III RPC2 | 0.0042 | 0.027 | 1 |
Brugia malayi | Animal haem peroxidase family protein | 0.0111 | 0.1143 | 1 |
Plasmodium falciparum | DNA-directed RNA polymerase II subunit RPB2, putative | 0.0042 | 0.027 | 0.062 |
Plasmodium vivax | DNA-directed RNA polymerase II subunit RPB2, putative | 0.0042 | 0.027 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0111 | 0.1143 | 1 |
Trypanosoma cruzi | RNA polymerase I second largest subunit, putative | 0.003 | 0.0121 | 0.1682 |
Plasmodium falciparum | DNA-directed RNA polymerase III subunit RPC2, putative | 0.0042 | 0.027 | 0.062 |
Mycobacterium leprae | DNA-DIRECTED RNA POLYMERASE (BETA CHAIN) RPOB (TRANSCRIPTASE BETA CHAIN) (RNA POLYMERASE BETA SUBUNIT) | 0.0813 | 1 | 0.5 |
Brugia malayi | Animal haem peroxidase family protein | 0.0111 | 0.1143 | 1 |
Schistosoma mansoni | peroxidasin | 0.0111 | 0.1143 | 1 |
Entamoeba histolytica | DNA-directed RNA polymerase subunit, putative | 0.0042 | 0.027 | 0.5 |
Leishmania major | DNA-directed RNA polymerase polypeptide, putative | 0.0042 | 0.027 | 1 |
Onchocerca volvulus | 0.0111 | 0.1143 | 1 | |
Schistosoma mansoni | DNA-directed RNA polymerase III subunit | 0.0042 | 0.027 | 0.2363 |
Brugia malayi | hypothetical protein | 0.0111 | 0.1143 | 1 |
Onchocerca volvulus | Peroxidase homolog | 0.0111 | 0.1143 | 1 |
Onchocerca volvulus | 0.0111 | 0.1143 | 1 | |
Giardia lamblia | DNA-directed RNA polymerase RPB2 | 0.0042 | 0.027 | 1 |
Entamoeba histolytica | DNA-directed RNA polymerase III subunit 127.6 kDa polypeptide, putative | 0.0042 | 0.027 | 0.5 |
Onchocerca volvulus | 0.0111 | 0.1143 | 1 | |
Loa Loa (eye worm) | DNA-directed RNA polymerase II second largest subunit | 0.0042 | 0.027 | 0.2363 |
Loa Loa (eye worm) | hypothetical protein | 0.0111 | 0.1143 | 1 |
Brugia malayi | Peroxidasin | 0.0111 | 0.1143 | 1 |
Onchocerca volvulus | Peroxidasin homolog | 0.0111 | 0.1143 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0111 | 0.1143 | 1 |
Entamoeba histolytica | DNA-directed RNA polymerase subunit, putative | 0.0042 | 0.027 | 0.5 |
Toxoplasma gondii | DNA-directed RNA polymerase II RPB2 | 0.0042 | 0.027 | 1 |
Echinococcus granulosus | DNA directed RNA polymerase II subunit RPB2 | 0.0042 | 0.027 | 0.2363 |
Echinococcus multilocularis | DNA directed RNA polymerase II subunit RPB2 | 0.0042 | 0.027 | 0.2363 |
Brugia malayi | Animal haem peroxidase family protein | 0.0111 | 0.1143 | 1 |
Mycobacterium tuberculosis | DNA-directed RNA polymerase (beta chain) RpoB (transcriptase beta chain) (RNA polymerase beta subunit) | 0.0199 | 0.2249 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
AUC (ADMET) | = 23287.97 ug/L.hr | AUC (0 to t) in ICR mouse at 5 mg/kg, iv | ChEMBL. | 21602044 |
AUC (ADMET) | = 23345.61 ug/L.hr | AUC (0 to infinity) in ICR mouse at 5 mg/kg, iv | ChEMBL. | 21602044 |
AUC (ADMET) | = 50159.54 ug/L.hr | AUC (0 to t) in ICR mouse at 10 mg/kg, po | ChEMBL. | 21602044 |
AUC (ADMET) | = 50205.11 ug/L.hr | AUC (0 to infinity) in ICR mouse at 10 mg/kg, po | ChEMBL. | 21602044 |
CL (ADMET) | = 0.21 L/hr/kg | Clearance in ICR mouse at 5 mg/kg, iv | ChEMBL. | 21602044 |
Cmax (ADMET) | = 31627.39 ug/L | Cmax in ICR mouse at 5 mg/kg, iv | ChEMBL. | 21602044 |
Cmax (ADMET) | = 42109.24 ug/L | Cmax in ICR mouse at 10 mg/kg, po | ChEMBL. | 21602044 |
Cp (ADMET) | = 42.35 ng/ml | Plasma concentration in ICR mouse at 10 mg/kg, po after 8 hrs by HPLC/MS/MS analysis | ChEMBL. | 21602044 |
Cp (ADMET) | = 45.34 ng/ml | Plasma concentration in ICR mouse at 5 mg/kg, iv after 8 hrs by HPLC/MS/MS analysis | ChEMBL. | 21602044 |
Cp (ADMET) | = 102.5 ng/ml | Plasma concentration in ICR mouse at 10 mg/kg, po after 6 hrs by HPLC/MS/MS analysis | ChEMBL. | 21602044 |
Cp (ADMET) | = 129.96 ng/ml | Plasma concentration in ICR mouse at 5 mg/kg, iv after 6 hrs by HPLC/MS/MS analysis | ChEMBL. | 21602044 |
Cp (ADMET) | = 206.42 ng/ml | Plasma concentration in ICR mouse at 5 mg/kg, iv after 4 hrs by HPLC/MS/MS analysis | ChEMBL. | 21602044 |
Cp (ADMET) | = 792.42 ng/ml | Plasma concentration in ICR mouse at 10 mg/kg, po after 4 hrs by HPLC/MS/MS analysis | ChEMBL. | 21602044 |
Cp (ADMET) | = 2238.74 ng/ml | Plasma concentration in ICR mouse at 5 mg/kg, iv after 2 hrs by HPLC/MS/MS analysis | ChEMBL. | 21602044 |
Cp (ADMET) | = 5308.82 ng/ml | Plasma concentration in ICR mouse at 10 mg/kg, po after 2 hrs by HPLC/MS/MS analysis | ChEMBL. | 21602044 |
Cp (ADMET) | = 6155.17 ng/ml | Plasma concentration in ICR mouse at 5 mg/kg, iv after 1 hr by HPLC/MS/MS analysis | ChEMBL. | 21602044 |
Cp (ADMET) | = 13724.93 ng/ml | Plasma concentration in ICR mouse at 5 mg/kg, iv after 0.5 hrs by HPLC/MS/MS analysis | ChEMBL. | 21602044 |
Cp (ADMET) | = 18032.43 ng/ml | Plasma concentration in ICR mouse at 5 mg/kg, iv after 0.25 hrs by HPLC/MS/MS analysis | ChEMBL. | 21602044 |
Cp (ADMET) | = 20897.3 ng/ml | Plasma concentration in ICR mouse at 10 mg/kg, po after 1 hr by HPLC/MS/MS analysis | ChEMBL. | 21602044 |
Cp (ADMET) | = 28495.37 ng/ml | Plasma concentration in ICR mouse at 10 mg/kg, po after 0.5 hrs by HPLC/MS/MS analysis | ChEMBL. | 21602044 |
Cp (ADMET) | = 31627.39 ng/ml | Plasma concentration in ICR mouse at 5 mg/kg, iv after 0.083 hrs by HPLC/MS/MS analysis | ChEMBL. | 21602044 |
Cp (ADMET) | = 41804.84 ng/ml | Plasma concentration in ICR mouse at 10 mg/kg, po after 0.083 hrs by HPLC/MS/MS analysis | ChEMBL. | 21602044 |
Cp (ADMET) | = 42109.24 ng/ml | Plasma concentration in ICR mouse at 10 mg/kg, po after 0.25 hrs by HPLC/MS/MS analysis | ChEMBL. | 21602044 |
Drug uptake (ADMET) | = 24.69 ng/g | Drug level in ICR mouse brain at 10 mg/kg, po after 4 hrs by HPLC/MS/MS analysis | ChEMBL. | 21602044 |
Drug uptake (ADMET) | = 64.88 ng/g | Drug level in ICR mouse brain at 5 mg/kg, iv after 2 hrs by HPLC/MS/MS analysis | ChEMBL. | 21602044 |
Drug uptake (ADMET) | = 162.13 ng/g | Drug level in ICR mouse brain at 10 mg/kg, po after 2 hrs by HPLC/MS/MS analysis | ChEMBL. | 21602044 |
Drug uptake (ADMET) | = 232.38 ng/g | Drug level in ICR mouse brain at 5 mg/kg, iv after 1 hr by HPLC/MS/MS analysis | ChEMBL. | 21602044 |
Drug uptake (ADMET) | = 516.3 ng/g | Drug level in ICR mouse brain at 10 mg/kg, po after 1 hr by HPLC/MS/MS analysis | ChEMBL. | 21602044 |
Drug uptake (ADMET) | = 522.59 ng/g | Drug level in ICR mouse brain at 5 mg/kg, iv after 0.5 hrs by HPLC/MS/MS analysis | ChEMBL. | 21602044 |
Drug uptake (ADMET) | = 758.97 ng/g | Drug level in ICR mouse brain at 5 mg/kg, iv after 0.25 hrs by HPLC/MS/MS analysis | ChEMBL. | 21602044 |
Drug uptake (ADMET) | = 949.69 ng/g | Drug level in ICR mouse brain at 10 mg/kg, po after 0.5 hrs by HPLC/MS/MS analysis | ChEMBL. | 21602044 |
Drug uptake (ADMET) | = 982.12 ng/g | Drug level in ICR mouse brain at 5 mg/kg, iv after 0.083 hrs by HPLC/MS/MS analysis | ChEMBL. | 21602044 |
Drug uptake (ADMET) | = 1156.67 ng/g | Drug level in ICR mouse brain at 10 mg/kg, po after 0.083 hrs by HPLC/MS/MS analysis | ChEMBL. | 21602044 |
Drug uptake (ADMET) | = 1265.99 ng/g | Drug level in ICR mouse brain at 10 mg/kg, po after 0.25 hrs by HPLC/MS/MS analysis | ChEMBL. | 21602044 |
F (ADMET) | = 107.53 % | Oral bioavailability ICR mouse at 10 mg/kg | ChEMBL. | 21602044 |
IC50 (binding) | = 1.23 nM | Inhibition of COX1 in human HEL 92.1.7 cells assessed as thromboxane B2 production incubated for 30 mins before arachidonic acid addition measured after 15 mins by ELISA | ChEMBL. | 21602044 |
IC50 (binding) | = 0.5 uM | Inhibition of ovine COX1 by EIA | ChEMBL. | 21602044 |
IC50 (binding) | = 0.53 uM | Inhibition of COX2 in LPS-stimulated and PMA-treated human U937 cells assessed as PGE2 production after 15 mins by ELISA | ChEMBL. | 21602044 |
Inhibition (binding) | Inhibition of COX1 in human HEL 92.1.7 cells assessed as thromboxane B2 production incubated for 30 mins before arachidonic acid addition measured after 15 mins by ELISA | ChEMBL. | 21602044 | |
Inhibition (functional) | = 50 % | Analgesic activity in Swiss albino mouse assessed as inhibition of acetic acid-induced writhing at 33.6 mg/kg, ig administered 1 hr before acetic acid challenge measured 10 mins post acetic acid challenge | ChEMBL. | 21602044 |
MRT (ADMET) | = 0.83 hr | Mean residence time (0 to infinity) in ICR mouse at 5 mg/kg, iv | ChEMBL. | 21602044 |
MRT (ADMET) | = 0.95 hr | Mean residence time (0 to infinity) in ICR mouse at 10 mg/kg, po | ChEMBL. | 21602044 |
Ratio IC50 (binding) | = 80 | Ratio of ibuprofen IC50 to compound IC50 for ovine COX1 expressed in human HEL 92.1.7 cells | ChEMBL. | 21602044 |
T1/2 (ADMET) | = 0.75 hr | Apparent half life in ICR mouse at 10 mg/kg, po | ChEMBL. | 21602044 |
T1/2 (ADMET) | = 0.88 hr | Apparent half life in ICR mouse at 5 mg/kg, iv | ChEMBL. | 21602044 |
Tmax (ADMET) | = 0.08 hr | Tmax in ICR mouse at 5 mg/kg, iv | ChEMBL. | 21602044 |
Tmax (ADMET) | = 0.25 hr | Tmax in ICR mouse at 10 mg/kg, po | ChEMBL. | 21602044 |
Vd (ADMET) | = 0.27 L/Kg | Apparent volume of distribution in ICR mouse at 5 mg/kg, iv | ChEMBL. | 21602044 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.